Imaging D2Receptor Occupancy by Endogenous Dopamine in Humans

The impact of endogenous dopamine on in vivo measurement of D2receptors in humans was evaluated with single photon emission computerized tomography (SPECT), by comparing the binding potential (BP) of the selective D2radiotracer [123I]IBZM before and after acute dopamine depletion. Dopamine depletion was achieved by administration of the tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (AMPT), given orally at a dose of 1 g every six hours for two days. AMPT increased [123I]IBZM BP by 28 ± 16% (±SD, n = 9). Experiments in rodents suggested that this effect was due to removal of endogenous dopamine rather than D2receptor upregulation. Synaptic dopamine concentration was estimated as 45 ± 25 nM, in agreement with values reported in rodents. The amplitude and the variability of the AMPT effect suggested that competition by endogenous dopamine introduces a significant error in measurement of D2receptors in vivo with positron emission tomography (PET) or SPECT. However, these results also imply that D2receptor imaging coupled with acute dopamine depletion might provide estimates of synaptic dopamine concentration in the living human brain.